Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global newborn screening market size attained a value of USD 1.20 billion in 2023. The market is likely to grow at a CAGR of 9% during the forecast period of 2024-2032, likely to attain a value of USD 2.60 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The introduction of various measures by governments to prevent the risk of disability and disease among infants is aiding the market growth. For instance, the Kerala government in India announced that it would initiate universal Comprehensive Newborn Screening (CNS) for newborns in public health facilities in the state in June 2018. Moreover, the advancing healthcare industry in middle- and low-income countries is increasing the accessibility to screening for newborn babies, which is catalysing the market growth. As the treatments are increasingly becoming cost-effective owing to technological advancements, the demand for newborn screening among all socioeconomic classes is increasing. The growing awareness regarding the importance of screening for newborn babies among parents, as it can potentially lead to adversaries such as learning disabilities, autism, retardation, dyslexia, and behavioural abnormalities, among others, is also surging the demand for newborn screening, therefore strengthening the market growth.
Newborn screening refers to screening tests of infants to detect any disease or health adversaries that can be treated after identification. It is conducted through blood tests, heart screening, and hearing screening to identify underlying health conditions of an infant to improve the overall quality of its life.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major technologies of newborn screening are:
The market can be broadly categorised on the basis of its test types into:
Based on product, the market is divided into:
The EMR report looks into the regional markets of newborn screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of complex and advanced diagnostic and screening methods to identify potential health conditions effectively is propelling the market growth. Moreover, the adoption of innovative technologies to diagnose genetic disorders and asymptomatic diseases for effective treatment of preventable and treatable diseases is augmenting the growth of the newborn screening industry. Although the market may be hindered due to the prevalence of false-positive and false-negative results, the increasing development of innovative and precise testing methods to eliminate the risk of false results is expected to significantly contribute to the market growth.
The rising deployment of components of molecular biology to analyse genetic mechanisms to detect diseases is invigorating the growth of the newborn screening industry. This is increasing the deployment of DNA microarray technology to increase the effectiveness of diagnosis, which is fuelling the market growth. In addition, the increasing research activities to minimise the side-effects of newborn screening methods while expanding the screening to diagnose more diseases is expected to provide impetus to the industry growth.
The report presents a detailed analysis of the following key players in the global newborn screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Technology |
|
Breakup by Test Type |
|
Breakup by Diseases Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
In 2023, the market attained a value of approximately USD 1.20 billion.
The market is expected to grow at a CAGR of 9% from 2024 to 2032 to reach a value of USD 2.60 billion by 2032.
The market is being aided by the improving health infrastructure in the developing countries and the growing cost-effectiveness of newborn screening.
The industry is expected to be driven by the growing development of advanced screening tests, the adoption of innovative technologies, and the increasing research activities to minimise the side-effects of newborn screening methods.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major technologies of newborn screening in the industry are tandem mass spectrometry, pulse oximetry, enzyme based assays, DNA assays, and electrophoresis.
The significant test types in the market are dry blood spot tests, critical congenital heart disease, and hearing screening tests.
The various products of newborn screening are instruments and reagents and assay kits.
The major players in the industry are Natus Medical, Inc., Masimo Corporation, AB Sciex, LLC, Medtronic PLC, Intelligent Hearing Systems Corporation, and Waters Corporation, among others.
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Pricing Plans
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-120-433-0800
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124